NCT/Study#
NA /
2020-0081
Outcomes Of Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Patients: Real World Experience In Lymphoma Patients
DISEASE GROUP:
Lymphoma
current phase:
NA
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
